Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03999879 · ClinicalTrials.gov registry record
PhosphoRus, Proton Imaging and Amyloid BuRdEn (PREPARE) ON AMYLOID BURDEN AND COGNITION
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 37
- Enrollment target
NCT03999879 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 37 participants.
The verdict
NCT03999879 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
Normal cells primarily produce energy with the help of the "mitochondria". These "small organs" are also called the "powerhouses of the cell" turn the sugars, fats and proteins that is eaten into forms of chemical energy that the body can use to carry on living. This process is called oxidative phosphorylation. In addition to the help from the mitochondria and oxidative phosphorylation, most cells can produce energy by lactic acid fermentation. This process is less energy efficient but faster and used by the brain, muscle or other organs under specific circumstances and energy demands, even in the presence of abundant oxygen. It is also called aerobic glycolysis. Aerobic glycolysis and oxidative phosphorylation are the two major mechanisms involved in brain energetics.
Interventions
- DIAGNOSTIC_TEST Measure of OxPhos upregulation
- DIAGNOSTIC_TEST lactate (measured with 1H-MRSI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2023-02-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03999879
The ClinicalTrials.gov registry entry for NCT03999879 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Measure of OxPhos upregulation is the first listed.
NCT03999879 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03999879 about?
NCT03999879 is a clinical study titled "PhosphoRus, Proton Imaging and Amyloid BuRdEn (PREPARE) ON AMYLOID BURDEN AND COGNITION". Normal cells primarily produce energy with the help of the "mitochondria". These "small organs" are also called the "powerhouses of the cell" turn the sugars, fats and proteins that is eaten into forms of chemical energy that the body can use to carry on living. This process is called oxidative phos...
What is the current status of trial NCT03999879?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2019-05-01. Estimated completion is 2023-02-24.
What interventions are being tested in trial NCT03999879?
The interventions under investigation include: Measure of OxPhos upregulation (DIAGNOSTIC_TEST), lactate (measured with 1H-MRSI) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03999879?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.